Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer ...

Piriformis syndrome is a condition that causes pain, numbness, or tingling in the buttocks and down the back of the leg. It occurs when the piriformis muscle spasms and compresses the sciatic nerve.

Andie MacDowell is battling a painful muscle condition called Piriformis syndrome. The Four Weddings and a Funeral star’s ...

or sciatica, for which Scilex has completed a Phase 3 study and was granted Fast Track status from the FDA in 2017; (ii) SP-103 (lidocaine topical system) 5.4%, ("SP-103"), a next-generation ...

Yes, there are lots of different ways of treating sciatica. Sciatica is the name given to pain that is felt in the buttock, and down the outside of the leg. It's caused by pressure on the sciatic ...

The nervous system is the body’s direct communication system. It’s made up of the body’s many nerve cells. These cells work together in a network that sends and receives signals from one ...

Optic neuritis (ON) is an inflammation that damages your optic nerve. It can cause vision loss and pain when you move your eyes. As the inflammation goes away, your symptoms usually get better ...

The Top Singles chart is France’s main singles chart, compiled by Official Charts Company for SNEP and SCPP, based on sales, airplay and streams in France. View the full chart here.

Vagus Nerve Stimulation therapy is a treatment for epilepsy that involves a stimulator (or 'pulse generator') which is connected, inside the body, to the left vagus nerve in the neck. The stimulator ...

Sciatica is the layman's term for neurologic symptoms that typically occur when nerves are being compressed or damaged, says Dr. Michael Gerling, American Board Certified Orthopedic Spine Surgeon.

With numerous day trading chart providers available in the market, choosing the right one can be a daunting task. To assist you in this endeavor, Benzinga has compiled a comparison list of some of ...

or sciatica, for which Scilex has completed a Phase 3 study and was granted Fast Track status from the FDA in 2017; (ii) SP-103 (lidocaine topical system) 5.4%, (“SP-103”), a next-generation ...